XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated balance sheet - CAD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash $ 1,467 [1] $ 771
Accounts receivable - net [2] 2,388 1,919
Inventories of crude oil and products 1,256 1,161
Materials, supplies and prepaid expenses 737 673
Total current assets 5,848 4,524
Investments and long-term receivables [3] 765 781
Property, plant and equipment, 55,911 55,771
less accumulated depreciation and depletion (24,211) (23,737)
Property, plant and equipment, net 31,700 32,034
Goodwill (note 11) 166 166
Other assets, including intangibles - net 528 526
Total assets 39,007 38,031
Current liabilities    
Notes and loans payable [4] 191 227
Accounts payable and accrued liabilities (note 7) [2] 3,721 3,153
Income taxes payable 21 0
Total current liabilities 3,933 3,380
Long-term debt (note 6) [5] 4,953 4,957
Other long-term obligations (note 7) 4,094 4,100
Deferred income tax liabilities 4,291 4,176
Total liabilities 17,271 16,613
Shareholders' equity    
Common shares at stated value (note 9) [6] 1,357 1,357
Earnings reinvested 22,281 22,050
Accumulated other comprehensive income (loss) (note 10) (1,902) (1,989)
Total shareholders' equity 21,736 21,418
Total liabilities and shareholders' equity $ 39,007 $ 38,031
[1] Cash is composed of cash in bank and cash equivalents at cost. Cash equivalents are all highly liquid securities with maturity of three months or less when purchased.
[2] Accounts receivable - net included net amounts receivable from related parties of $361 million (2020 - $384 million).
[3] Investments and long-term receivables included amounts from related parties of $300 million (2020 - $313 million).
[4] Notes and loans payable included amounts to related parties of $75 million (2020 - $111 million).
[5] Long-term debt included amounts to related parties of $4,447 million (2020 - $4,447 million).
[6] Number of common shares authorized and outstanding were 1,100 million and 734 million, respectively (2020 - 1,100 million and 734 million, respectively).